RAD 2023: Incyte Poster | MarketScreener
396 Rapid,... | May 1, 2023
Stay updated with breaking news from Arena Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ad hoc announcement pursuant to Art. 53 LR Zug, 3 April 2023 Alpine Select Ltd.: Annual results, portfolio development and investment... | April 3, 2023
NEW ORLEANS — Phase 3 trial results found delgocitinib cream to significantly improve patient and clinician-reported outcomes of hand eczema, according to a presenter at the American Academy of Dermatology Annual Meeting.“Chronic hand eczema is one of the most frequent and chronic inflammatory disorders affecting hands,” Robert Bissonnette, MD, MSc, CEO and medical director of
Previously relegated to underground communities and raves, ketamine, MDMA and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches.
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week